CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

STAQ Pharma, Inc. recalls Ketamine Hydrochloride and 2 more

Read the official FDA notice

Published
22 Oct 2025
Units affected
3 products
Agency
FDA
Country
United States

The hazard

Labeling: Incorrect or Missing Lot and/or Exp Date

Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Ketamine Hydrochloride, 50mg/5 mL (10mg/mL), Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0156-02.

Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0104-05.

FentaNYL Citrate PF, 500mcg/50 mL (10mcg/mL) in NACL, Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0102-05.

Brand / company
STAQ Pharma, Inc.
Codes / lots
Lot #: 25156673A, Expiry: 02FEB2026. | Lot #: 25104595A, Expiry: 27DEC2025. | Lot: 25102464B, Expiry: 26NOV2025; 25102370A, Expiry: 20OCT2025; 25102369A, Expiry: 19OCT2025.
Distribution
Nationwide in the U.S.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 22 Oct 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.